Cited by 2,621Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular HealthParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE

Miller, G.J, Miller, N.E·1975·The Lancet

DOI 10.1016/s0140-6736(75)92376-4

Open this paper in CoChat — free account

Abstract

The body cholesterol pool increases with decreasing plasma-high-density-lipoprotein (H.D.L.) but is unrelated to the plasma concentrations of total cholesterol and other lipoproteins. This finding supports existing evidence that H.D.L. facilitates the uptake of cholesterol from peripheral tissues and its transport to the liver for catabolism and excretion. Plasma-H.D.L., is reduced in several conditions associated with an increased risk of future ischaemic heart-disease (I.H.D.), namely hypercholesterolaemia, hypertriglyceridaimia, male sex, obesity, and diabetes mellitus, while subjects with existing clinical I.H.D. have lower levels of H.D.L. than healthy subjects within the same community. It is proposed that a reduction of plasma-H.D.L. concentration may accelerate the development of atherosclerosis, and hence I.H.D., by impairing the clearance of cholesterol from the arterial wall.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(75)92376-4

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,396
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,911
ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL
Carlson, L., & Böttiger, L. E. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90738-6 · Cited by 752
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91658-8 · Cited by 690
Protein-lipid relationships in human plasma
Barr, D. P., Russ, E. M., & Eder, H. A. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90183-0 · Cited by 635
RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES
Slack, J. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90930-1 · Cited by 625
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1986.tb07607.x · Cited by 604
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701192760305 · Cited by 526
VIGOROUS EXERCISE IN LEISURE-TIME AND THE INCIDENCE OF CORONARY HEART-DISEASE
Morris, J. N., Chave, S. P. W., Adam, C., Sirey, C., Epstein, L. H., & Sheehan, D. J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90128-1 · Cited by 456

Show all 59 references

Research works printed but not linked: 13

Miller, 1973, J. Lab. clin. Med., 82, 876
Goodman, 1973, J. Lipid Res., 52, 2646
Insull, 1968, J. Lab. clin. Med., 72, 885
Schreibman, 1973, Clin. Res., 21, 638
P. Clifton-Bligh, N.E. Miller, P.J. Nestel, Clin. Sci. ((in the press)).
Nikkilä, 1953, Scand. J. clin. Lab. Invest., 5
Fredrickson, 1968, J. clin. Invest., 47, 2446, 10.1172/JCI105927 · DOI
N.E. Miller, P.J. Nestel, Eur. J. clin. Invest. ((in the press)).
Kannel, 1962, Geriatrics, 17, 675
Murphy, 1962, J. Lab. clin. Med., 60, 86
Kudchodkar, 1972, Clin. Res., 20, 944
Jones, 1970, J. Lab. clin. Med., 75, 953
Bondjers, 1974, Proc. Eur. Soc. clin. Invest., 8, 123

Sorted by citations

High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,400
Mendelian randomization
Sanderson, E., Glymour, M. M., Holmes, M. V., Kang, H., Morrison, J., Munafò, M. R., Palmer, T., Schooling, C. M., Wallace, C., Zhao, Q., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00092-5 · Cited by 2,229
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
High-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study
Castelli, W. P., Doyle, J. T., Gordon, T., Hames, C. G., Hjortland, M. C., Hulley, S. B., Kagan, A., & Zukel, W. J. (1977) · Circulation · doi:10.1161/01.cir.55.5.767 · Cited by 1,492
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,372
The Bogalusa Heart Study
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Springer eBooks · doi:10.1007/978-3-642-95642-3_7 · Cited by 1,331
Cholesterol in the Prediction of Atherosclerotic Disease
Kannel, W. B., Castelli, W. P., & Gordon, T. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-1-85 · Cited by 1,314
A comprehensive evaluation of the heparin–manganese precipitation procedure for estimating high density lipoprotein cholesterol
Warnick, G. R., & Albers, J. J. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41577-9 · Cited by 1,248
Prospective study of alcohol consumption and risk of coronary disease in men.
Rimm, E. B., Giovannucci, E. L., Willett, W. C., Colditz, G. A., Ascherio, A., Rosner, B., & Stampfer, M. J. (1991) · The Lancet · doi:10.1016/0140-6736(91)90542-w · Cited by 1,239
Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
Tangvarasittichai, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.456 · Cited by 1,284
High density lipoprotein metabolism.
Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,212
THE TROMSØHEART-STUDY
Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,206
Self-citation
Use of metabolic markers to identify overweight individuals who are insulin resistant
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00007 · Cited by 1,022
Dietary influences on serum lipids and lipoproteins.
Grundy, S. M., & Denke, M. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42625-2 · Cited by 1,044
Moderate Alcohol Intake, Increased Levels of High-Density Lipoprotein and Its Subfractions, and Decreased Risk of Myocardial Infarction
Gaziano, J. M., Buring, J. E., Breslow, J. L., Goldhaber, S. Z., ROSNER, B. A., VanDenburgh, M., Willett, W. C., & Hennekens, C. H. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312163292501 · Cited by 1,012
Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary Events
Robins, S. J., Collins, D. E., Wittes, J. T., Papademetriou, V., DEEDWANIA, P. C., Schaefer, E. J., McNamara, J. R., Kashyap, M. L., Hershman, J. M., WEXLER, L. F., et al. (2001) · JAMA · doi:10.1001/jama.285.12.1585 · Cited by 917
A Prospective Study of Moderate Alcohol Consumption and the Risk of Coronary Disease and Stroke in Women
Stampfer, M. J., Colditz, G. A., Willett, W. C., Speizer, F. E., & Hennekens, C. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808043190503 · Cited by 892
Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese Men
Rhoads, G. G., Gulbrandsen, C. L., & Kagan, A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602052940601 · Cited by 876
The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease
Pace-Asciak, C. R., Hahn, S., Diamandis, E. P., Soleas, G. J., & Goldberg, D. M. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06045-1 · Cited by 877
A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart Disease
Stampfer, M. J., Willett, W. C., Colditz, G. A., ROSNER, B. A., Speizer, F. E., & Hennekens, C. H. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510243131703 · Cited by 855
High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
Parthasarathy, S., Barnett, J., & Fong, L. G. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90314-n · Cited by 827
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
Self-citation
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3
Navab, M., Hama, S. Y., Anantharamaiah, G. M., Hassan, K., Hough, G. P., Watson, A. D., Reddy, S. T., Sevanian, A., Fonarow, G. C., & Fogelman, A. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33462-3 · Cited by 663
Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study
Kannel, W. B. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90224-8 · Cited by 664
Is There a Simple Way to Identify Insulin-Resistant Individuals at Increased Risk of Cardiovascular Disease?
McLaughlin, T., Reaven, G. M., Abbasi, F., Lamendola, C. A., Saad, M. F., Waters, D. D., Simon, J., & Krauss, R. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.085 · Cited by 659
Social class and coronary heart disease.
Rose, G., & Marmot, M. G. (1981) · Heart · doi:10.1136/hrt.45.1.13 · Cited by 644
High density lipoprotein cholesterol and mortality. The Framingham Heart Study.
Wilson, P. W. F., Abbott, R. D., & Castelli, W. P. (1988) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.8.6.737 · Cited by 644
PLASMA LIPID TRANSFER PROTEINS
Tall, A. R. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.001315 · Cited by 639
ATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017
Faludi, A., Izar, M. C. D. O., Saraiva, J., Chacra, A., Bianco, H. T., Neto, A. A., Bertolami, A., Pereira, A., Lottenberg, A., Sposito, A. C., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170121 · Cited by 690
Characterization of human high-density lipoproteins by gradient gel electrophoresis
Blanche, P. J., Gong, E. L., Forte, T. M., & Nichols, A. V. (1981) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(81)90253-8 · Cited by 614
Molecular regulation of HDL metabolism and function: implications for novel therapies
Rader, D. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci30163 · Cited by 610
Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.
Zhong, S., Sharp, D. S., Grove, J., Bruce, C., Yano, K., Curb, J. D., & Tall, A. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118751 · Cited by 579
Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary review
Carlson, L. A. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01528.x · Cited by 591
Coronary heart disease in South Asians overseas: A review
McKeigue, P. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90002-4 · Cited by 579
Relationship between obesity, insulin resistance, and coronary heart disease risk
Abbasi, F., Brown, B. W., Lamendola, C. A., McLaughlin, T., & Reaven, G. M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02051-x · Cited by 580
Insulin and Atheroma: 20-Yr Perspective
Stout, R. W. (1990) · Diabetes Care · doi:10.2337/diacare.13.6.631 · Cited by 569
A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum.
Chapman, M. J., Goldstein, S., Lagrange, D., & Laplaud, P. M. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35376-1 · Cited by 553
Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor.
Chung, B. H., Wilkinson, T., Geer, J. C., & Segrest, J. P. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39807-2 · Cited by 546
Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., & Mao, S. J. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090701 · Cited by 537
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome
Grundy, S. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00033-2 · Cited by 525
Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.
Heiss, G., Tamir, I., Davis, C. E., Tyroler, H. A., Rifkand, B. M., Schonfeld, G., Jacobs, D., & Frantz, I. D. (1980) · Circulation · doi:10.1161/01.cir.61.2.302 · Cited by 526
Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.
Groot, P. H. E., van Stiphout, W. A. H. J., Krauss, X. H., Jansen, H., van Tol, A., van Ramshorst, E., Chin-On, S., Albert Hofman, D., Cresswell, S. R., & Havekes, L. M. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.3.653 · Cited by 528
Macrophage Reverse Cholesterol Transport
Cuchel, M., & Rader, D. J. (2006) · Circulation · doi:10.1161/circulationaha.104.475715 · Cited by 536
ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?
Avogaro, P., Bon, G. B., Avogaro, P., Cazzolato, G., & Quinci, G. B. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91375-8 · Cited by 523
LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture
Hessler, J. R., Robertson, A. L., & Chisolm, G. M. (1979) · Atherosclerosis · doi:10.1016/0021-9150(79)90166-7 · Cited by 505
The Primary Prevention of Myocardial Infarction
Manson, J. E., Tosteson, H., Ridker, P. M., Satterfield, S., Hebert, P., O'Connor, G. T., Buring, J. E., & Hennekens, C. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205213262107 · Cited by 508
Plasma High-Density Lipoproteins
Tall, A. R., & SMALL, D. M. (1978) · New England Journal of Medicine · doi:10.1056/nejm197811302992207 · Cited by 500
Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
Mackness, M., Harty, D. W. S., Bhatnagar, D., Winocour, P. H., Arrol, S., Ishola, M., & Durrington, P. N. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90215-o · Cited by 492
Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study.
Lemieux, I., Lamarche, B., Couillard, C., Pascot, A., Cantin, B., Bergeron, J., Dagenais, G., & Despres, J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.22.2685 · Cited by 551
In vivo protection against endotoxin by plasma high density lipoprotein.
Levine, D. M., Parker, T. S., Donnelly, T. M., Walsh, A., & Rubin, A. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12040 · Cited by 485
Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales.
Balarajan, R. (1991) · BMJ · doi:10.1136/bmj.302.6776.560 · Cited by 484
ABCA1: the gatekeeper for eliminating excess tissue cholesterol
Oram, J. F., & Lawn, R. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31566-2 · Cited by 481
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.
Franceschini, G., Sirtori, C. R., Capurso, A., Weisgraber, K. H., & Mahley, R. W. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109956 · Cited by 470
Effects of Dietary Polyunsaturated and Saturated Fat on the Properties of High Density Lipoproteins and the Metabolism of Apolipoprotein A-I
Shepherd, J., Packard, C. J., Patsch, J. R., Gotto, A. M., & Taunton, O. D. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109078 · Cited by 456
Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients.
Rath, M., Niendorf, A., Reblin, T., Dietel, M., Krebber, H.-J., & Beisiegel†, U. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.5.579 · Cited by 446
Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation
Borhani, D. W., Rogers, D. P., Engler, J. A., & Brouillette, C. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12291 · Cited by 434
The metabolic syndrome: requiescat in pace
Reaven, G. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.048611 · Cited by 427
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423
Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I
Martin, G., Duez, H., Blanquart, C., Bérézowski, V., Poulain, P., Fruchart, J., Najib-Fruchart, J., Glineur, C., & Staels, B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10852 · Cited by 419
Multifactorial causation of obesity: implications for prevention
Grundy, S. M. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.3.563s · Cited by 403
The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program: An Approach to Accurate and Precise Lipid Measurements
Myers, G. L., Cooper, G. R., Winn, C., & Smith, S. J. (1989) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30645-0 · Cited by 404
High-density lipoprotein revisited: biological functions and clinical relevance
von Eckardstein, A., Nordestgaard, B. G., Remaley, A. T., & Catapano, A. L. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehac605 · Cited by 401
Insulin Resistance: the Link Between Obesity and Cardiovascular Disease
Reaven, G. M. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.06.002 · Cited by 417
Effects of ethanol on lipid metabolism.
Baraona, E., & Lieber, C. S. (1979) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40613-3 · Cited by 392
Isolated Low HDL Cholesterol As a Risk Factor for Coronary Heart Disease Mortality
Goldbourt, U., Yaari, S., & Medalie, J. H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.1.107 · Cited by 390
PLASMA EXCHANGE IN THE MANAGEMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIA
Thompson, G. R., Lowenthal, R. M., & Myant, N. B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92193-5 · Cited by 390
Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins
Abbott, C. A., Mackness, M., Kumar, S., Boulton, A. J. M., & Durrington, P. N. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1812 · Cited by 387
Plasma Sphingomyelin Level as a Risk Factor for Coronary Artery Disease
Jiang, X.-C., Paultre, F., Pearson, T. A., Reed, R. G., Francis, C. K., Lin, M., Berglund, L., & Tall, A. R. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.12.2614 · Cited by 387
Coronary risk prediction in adults (The Framingham Heart Study)
Wilson, P. W. F., Castelli, W. P., & Kannel, W. B. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90165-2 · Cited by 381
The Measurement of Apolipoprotein A-I and A-II Levels in Men and Women by Immunoassay
Cheung, M. C., & Albers, J. J. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108767 · Cited by 381
High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.
Patsch, J. R., Prasad, S. C., Gotto, A. M., & Patsch, W. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113078 · Cited by 377
Plasma lipid transfer proteins.
Tall, A. R. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38819-2 · Cited by 377
Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification
Mackness, B., Mackness, M., Arrol, S., Turkie, W., & Durrington, P. N. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00064-7 · Cited by 376
The metabolic syndrome: time for a critical appraisal
Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2005) · Diabetologia · doi:10.1007/s00125-005-1876-2 · Cited by 384
Diabetes, Blood Lipids, and the Role of Obesity in Coronary Heart Disease Risk for Women
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-4-393 · Cited by 368
The distribution of plasma lipoproteins in middle-aged male runners
Wood, P. D., Haskell, W. L., Klein, H., Lewis, S. F., D, M. P. S. M., & Farquhar, J. W. (1976) · Metabolism · doi:10.1016/s0026-0495(76)80008-x · Cited by 363
Plasma Lipids and Lipoproteins in Vegetarians and Controls
Sacks, F. M., Castelli, W. P., Donner, A., & Kass, E. H. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505292922203 · Cited by 356
HDL-targeted therapies: progress, failures and future
Kingwell, B. A., Chapman, M. J., Kontush, A., & Miller, N. E. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4279 · Cited by 354
Self-citation
Increased exercise level and plasma lipoprotein concentrations: A one-year, randomized, controlled study in sedentary, middle-aged men
Wood, P. D., Haskell, W. L., Blair, S. N., Williams, P. T., Krauss, R. M., Lindgren, F. T., Albers, J. J., Ho, P., & Farquhar, J. W. (1983) · Metabolism · doi:10.1016/0026-0495(83)90152-x · Cited by 354
Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography.
Weisgraber, K. H., & Mahley, R. W. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39811-4 · Cited by 347
Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement Therapy
Hirvonen, E., Mälkönen, M., & Manninen, V. (1981) · New England Journal of Medicine · doi:10.1056/nejm198103053041002 · Cited by 345
Untitled work
(1981) · PubMed · Cited by 341
Human plasma phospholipid transfer protein causes high density lipoprotein conversion.
Jauhiainen, M., Metso, J., Pahlman, R., Blomqvist, S., van Tol, A., & Ehnholm, C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53575-4 · Cited by 342
Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
Oram, J. F., & Yokoyama, S. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37453-8 · Cited by 342
Quantitation of apolipoprotein A-I of human plasma high density lipoprotein
Albers, J. J., WAHL, P. W., Cabana, V. G., Hazzard, W. R., & Hoover, J. (1976) · Metabolism · doi:10.1016/0026-0495(76)90060-3 · Cited by 342
High-density lipoproteins: A consensus statement from the National Lipid Association
Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.08.001 · Cited by 336
The Effects of Estrogen Administration on Plasma Lipoprotein Metabolism in Premenopausal Females
Schaefer, E. J., Foster, D. M., Zech, L. A., Lindgren, F. T., Brewer, H. B., & Levy, R. I. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-262 · Cited by 337
A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids
Navab, M., Hama, S. Y., Hough, G. P., Subbanagounder, G., Reddy, S. T., & Fogelman, A. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31582-0 · Cited by 334
Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease
Genest, J. J., McNamara, J. R., Ordovás, J. M., Jenner, J. L., Silberman, S. R., Anderson, K. M., Wilson, P. W. F., Salem, D. N., & Schaefer, E. J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90520-w · Cited by 333
Oxidation of High Density Lipoproteins
Garner, B., Waldeck, A. R., Witting, P. K., Rye, K.-A., & Stocker, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6088 · Cited by 324
High-Density Lipoprotein Cholesterol and Ischemic Stroke in the Elderly: The Northern Manhattan Stroke Study
Sacco, R. L., Benson, R. T., Kargman, D. E., Boden-Albala, B., Tuck, C., Lin, I.-F., Cheng, J. F., Paik, M. C., Shea, S., & Berglund, L. (2001) · JAMA · doi:10.1001/jama.285.21.2729 · Cited by 311
Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome.
Cheal, K. L., Abbasi, F., Lamendola, C., McLaughlin, T., Reaven, G. M., & Ford, E. S. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1195 · Cited by 312
Cigarette smoking and HDL cholesterol the Framingham offspring study
Garrison, R. J., Kannel, W. B., Feinleib, M., Castelli, W. P., Pm, M., & Padgett, S. J. (1978) · Atherosclerosis · doi:10.1016/0021-9150(78)90149-1 · Cited by 311
Lipid Metabolism and Ischemic Heart Disease in Greenland Eskimos
Bang, H. O., & Dyerberg, J. (1980) · Springer eBooks · doi:10.1007/978-1-4757-4448-4_1 · Cited by 304
Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery Disease
Norum, R. A., Lakier, J. B., Goldstein, S., Angel, A., Goldberg, R. B., Block, W. D., Noffze, D. K., Dolphin, P. J., Edelglass, J. W., Bogorad, D. D., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206243062503 · Cited by 303
The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation
Mackness, M., Abbott, C. A., Arrol, S., & Durrington, P. N. (1993) · Biochemical Journal · doi:10.1042/bj2940829 · Cited by 304

Authors: Miller, G. J., & Miller, N. E.
Affiliations: University Hospital Llandough (GB)
Edinburgh Royal Infirmary (GB)
ORCID: Miller, G.J
Venue: The Lancet
Publisher: Elsevier BV
Published: 1975-01
Volume: 305
Issue: 7897
Pages: 16-19
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(75)92376-4
OpenAlex: W1994967652
Cited by: 2,621
References: 59
Citations by year: 2026: 5 · 2025: 11 · 2024: 9 · 2023: 7 · 2022: 15 · 2021: 17 · 2020: 24 · 2019: 18 · 2018: 18 · 2017: 17 · 2016: 29 · 2015: 29 · 2014: 22 · 2013: 32 · 2012: 26
FWCI: 157.87
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: high-density lipoprotein, ischemic heart disease, atherosclerosis, cholesterol metabolism, hypercholesterolemia, hypertriglyceridemia, obesity, diabetes mellitus, sex differences, cardiovascular risk factors
MeSH terms: Arteries, Arteriosclerosis, Cholesterol, Coronary Disease, Denmark, Inuit, Female, Finland, Humans, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Liver, Male, Middle Aged, Sex Factors, Sweden, Triglycerides, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks